Michael Carrier
Stock Analyst at Oppenheimer
(4.90)
# 33
Out of 4,784 analysts
226
Total ratings
70.25%
Success rate
22.18%
Average return
Main Sectors:
Stocks Rated by Michael Carrier
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAR Pharming Group | Maintains: Outperform | $30 → $39 | $8.31 | +369.31% | 3 | Mar 14, 2025 | |
| CBOE Cboe Global Markets | Maintains: Buy | $245 → $251 | $222.68 | +12.72% | 18 | Feb 10, 2025 | |
| MS Morgan Stanley | Maintains: Buy | $146 → $153 | $115.33 | +32.66% | 13 | Jan 17, 2025 | |
| NTRS Northern Trust | Maintains: Buy | $103 → $115 | $97.15 | +18.37% | 12 | Oct 24, 2024 | |
| TW Tradeweb Markets | Maintains: Buy | $134 → $139 | $146.77 | -5.29% | 6 | Oct 3, 2024 | |
| GS The Goldman Sachs Group | Downgrades: Neutral | $490 → $475 | $543.12 | -12.54% | 6 | Jan 6, 2022 | |
| AB AllianceBernstein Holding L.P. | Downgrades: Neutral | $42 | $38.37 | +9.46% | 12 | Apr 9, 2021 | |
| VCTR Victory Capital Holdings | Upgrades: Buy | $24 → $32 | $57.44 | -44.29% | 4 | Apr 9, 2021 | |
| BK The Bank of New York Mellon Corporation | Upgrades: Buy | $43 → $50 | $82.71 | -39.55% | 10 | Mar 24, 2021 | |
| CME CME Group | Upgrades: Buy | $200 → $220 | $262.22 | -16.10% | 10 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $19 → $14 | $10.35 | +35.27% | 1 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $68 | $77.81 | -12.61% | 9 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $154 | $91.57 | +68.18% | 9 | Nov 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 | $78.56 | -3.26% | 9 | Nov 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $26 | $19.28 | +34.85% | 9 | Oct 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $70 | $89.04 | -21.38% | 10 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $633 → $675 | $946.70 | -28.70% | 6 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $154 | $173.25 | -11.11% | 7 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $15.19 | -27.58% | 6 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $70 → $71 | $167.21 | -57.54% | 5 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $40 | $114.86 | -65.18% | 6 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $25 → $27 | $43.15 | -37.43% | 10 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $58 | $138.11 | -58.00% | 5 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $44 | $144.90 | -69.63% | 7 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $54 → $53 | $136.96 | -61.30% | 3 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $47 | $74.91 | -37.70% | 7 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $16.70 | - | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $17 → $13 | $35.98 | -63.87% | 2 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $22 → $15 | $40.69 | -63.14% | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $23 → $18 | $39.12 | -53.99% | 3 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $81 | $174.71 | -53.64% | 4 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $57 → $39 | $1.09 | +3,477.98% | 9 | Oct 2, 2019 |
Pharming Group
Mar 14, 2025
Maintains: Outperform
Price Target: $30 → $39
Current: $8.31
Upside: +369.31%
Cboe Global Markets
Feb 10, 2025
Maintains: Buy
Price Target: $245 → $251
Current: $222.68
Upside: +12.72%
Morgan Stanley
Jan 17, 2025
Maintains: Buy
Price Target: $146 → $153
Current: $115.33
Upside: +32.66%
Northern Trust
Oct 24, 2024
Maintains: Buy
Price Target: $103 → $115
Current: $97.15
Upside: +18.37%
Tradeweb Markets
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $139
Current: $146.77
Upside: -5.29%
The Goldman Sachs Group
Jan 6, 2022
Downgrades: Neutral
Price Target: $490 → $475
Current: $543.12
Upside: -12.54%
AllianceBernstein Holding L.P.
Apr 9, 2021
Downgrades: Neutral
Price Target: $42
Current: $38.37
Upside: +9.46%
Victory Capital Holdings
Apr 9, 2021
Upgrades: Buy
Price Target: $24 → $32
Current: $57.44
Upside: -44.29%
The Bank of New York Mellon Corporation
Mar 24, 2021
Upgrades: Buy
Price Target: $43 → $50
Current: $82.71
Upside: -39.55%
CME Group
Mar 24, 2021
Upgrades: Buy
Price Target: $200 → $220
Current: $262.22
Upside: -16.10%
Mar 24, 2021
Downgrades: Underperform
Price Target: $19 → $14
Current: $10.35
Upside: +35.27%
Jan 12, 2021
Upgrades: Buy
Price Target: $68
Current: $77.81
Upside: -12.61%
Nov 19, 2020
Downgrades: Neutral
Price Target: $154
Current: $91.57
Upside: +68.18%
Nov 19, 2020
Upgrades: Buy
Price Target: $76
Current: $78.56
Upside: -3.26%
Oct 9, 2020
Upgrades: Buy
Price Target: $26
Current: $19.28
Upside: +34.85%
Jul 20, 2020
Maintains: Buy
Price Target: $71 → $70
Current: $89.04
Upside: -21.38%
Jul 20, 2020
Maintains: Buy
Price Target: $633 → $675
Current: $946.70
Upside: -28.70%
Jul 10, 2020
Maintains: Buy
Price Target: $140 → $154
Current: $173.25
Upside: -11.11%
Jul 10, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $15.19
Upside: -27.58%
Jul 10, 2020
Maintains: Underperform
Price Target: $70 → $71
Current: $167.21
Upside: -57.54%
Jul 10, 2020
Maintains: Buy
Price Target: $36 → $40
Current: $114.86
Upside: -65.18%
Jul 10, 2020
Maintains: Underperform
Price Target: $25 → $27
Current: $43.15
Upside: -37.43%
Jul 10, 2020
Maintains: Neutral
Price Target: $62 → $58
Current: $138.11
Upside: -58.00%
Jul 10, 2020
Maintains: Buy
Price Target: $43 → $44
Current: $144.90
Upside: -69.63%
Jul 10, 2020
Maintains: Neutral
Price Target: $54 → $53
Current: $136.96
Upside: -61.30%
Jul 10, 2020
Maintains: Buy
Price Target: $43 → $47
Current: $74.91
Upside: -37.70%
Mar 24, 2020
Downgrades: Perform
Price Target: n/a
Current: $16.70
Upside: -
Mar 23, 2020
Maintains: Underperform
Price Target: $17 → $13
Current: $35.98
Upside: -63.87%
Mar 23, 2020
Maintains: Underperform
Price Target: $22 → $15
Current: $40.69
Upside: -63.14%
Mar 23, 2020
Maintains: Underperform
Price Target: $23 → $18
Current: $39.12
Upside: -53.99%
Mar 23, 2020
Maintains: Buy
Price Target: $99 → $81
Current: $174.71
Upside: -53.64%
Oct 2, 2019
Downgrades: Underperform
Price Target: $57 → $39
Current: $1.09
Upside: +3,477.98%